MarketInOut Stock Screener Log In | Sign Up

Arcutis Biotherapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Arcutis Biotherapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4,030.94 mln
Float110 mln
Earnings Date11/04/2026

EPS

0.22
Overpriced

P / E

146
Highly speculative

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.03
Caution advised

1-Year Forecast

39.12
Attractive

Relative Strength

92 / 100
Top performer

Business Description

Arcutis Biotherapeutics is a California-based company founded in 2016 that researches and brings to market new medicines for skin conditions. Its flagship product, ZORYVE, is available as both a cream and a foam to treat conditions such as plaque psoriasis, atopic dermatitis, and seborrheic dermatitis. The company is also working on an experimental treatment called ARQ-234, which targets the immune system to address skin disease in a novel way.

Key Fundamentals

EPS0.22
P/E146
ROE15.90
RPS3.60
ROIC35.04
ROA6.77
Interest Cover2.47
EBITDA, mln46.09
EV / EBITDA89.54
EV / EBIT95.67
Revenue, mln464
EV / Revenue8.90

Quote Details

Last 32.07
Change 0.1 (0.31%)
Open 32.34
Volume 1,882,316
Turnover 60,365,872
Average Volume 2,265,292

Financial Ratios

Pre-Tax Profit Margin6
Leverage Ratio2.21
Current Ratio2.92
Price / Book18.04
Price / Tangible Book19.20
Price / Cash Flow106
Price / Free Cash Flow110
Debt / Equity0.52
Price / Sales9.12

Financial Strength

Altman Z-Score7.66
Piotroski F-Score 7 / 9
Beneish M-Score-2.03
Price to Graham Number11.44
1-Year Target Price39.12
Short Ratio6.13
Short % of Float17.38

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.79% 83 / 100   
1 Month 26.81% 98 / 100   
2 Months 15.19% 91 / 100   
6 Months 37.34% 94 / 100   
1 Year 26.81% 84 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog